Étude de phase 3 de l’ixékizumab versus adalimumab et...

Annales de Dermatologie et de Vénéréologie 2016 / 12 Vol. 143; Iss. 12

Étude de phase 3 de l’ixékizumab versus adalimumab et placebo chez des patients atteints de rhumatisme psoriasique naïfs de DMARDS biologiques

Mease, P., van der Heijde, D., Ritchlin, C., Cuchacovich, R., Shuler, C., Lin, C.-Y., Vangerow, H., Samanta, S., Lee, C., Gladman, D., Augendre-Ferrante, B.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
143
Language:
french
Journal:
Annales de Dermatologie et de Vénéréologie
DOI:
10.1016/j.annder.2016.09.647
Date:
December, 2016
File:
PDF, 51 KB
french, 2016
Conversion to is in progress
Conversion to is failed